These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 29522126)
1. Retinal Deposits in a Young Woman. Oliver R; Sallam AB; Uwaydat SH JAMA Ophthalmol; 2018 Jun; 136(6):708-709. PubMed ID: 29522126 [No Abstract] [Full Text] [Related]
2. Effect of velaglucerase alfa enzyme replacement therapy on red blood cell properties in Gaucher disease. Franco M; Reihani N; Marin M; De Person M; Billette de Villemeur T; Rose C; Colin Y; Moussa F; Belmatoug N; Le Van Kim C Am J Hematol; 2017 Sep; 92(9):E561-E563. PubMed ID: 28621801 [No Abstract] [Full Text] [Related]
3. The appearance of newly identified intraocular lesions in Gaucher disease type 3 despite long-term glucocerebrosidase replacement therapy. Sawicka-Gutaj N; Machaczka M; Kulińska-Niedziela I; Bernardczyk-Meller J; Gutaj P; Sowiński J; Ruchała M Ups J Med Sci; 2016 Aug; 121(3):192-5. PubMed ID: 27064303 [TBL] [Abstract][Full Text] [Related]
4. Fundus abnormalities in a patient with type I Gaucher's disease with 12-year follow-up. Wang TJ; Chen MS; Shih YF; Hwu WL; Lai MY Am J Ophthalmol; 2005 Feb; 139(2):359-62. PubMed ID: 15734007 [TBL] [Abstract][Full Text] [Related]
5. IgM monoclonal component associated with type I Gaucher disease resolved after enzyme replacement therapy: a case report. Martinez-Redondo C; Ortuño FJ; Lozano ML; Jerez A; del Mar Osma M; Giraldo P; Vicente V J Inherit Metab Dis; 2009 Dec; 32 Suppl 1():S265-7. PubMed ID: 19562501 [TBL] [Abstract][Full Text] [Related]
6. Functional retinal changes in Gaucher disease. Seidova SF; Kotliar K; Foerger F; Klopfer M; Lanzl I Doc Ophthalmol; 2009 Apr; 118(2):151-4. PubMed ID: 18777184 [TBL] [Abstract][Full Text] [Related]
7. Glucocerebrosidase level in the cerebrospinal fluid during enzyme replacement therapy--unsuccessful treatment of the neurological abnormality in type 2 Gaucher disease. Migita M; Hamada H; Fujimura J; Watanabe A; Shimada T; Fukunaga Y Eur J Pediatr; 2003 Jul; 162(7-8):524-525. PubMed ID: 12845529 [No Abstract] [Full Text] [Related]
8. Analysis of the pre-retinal opacities in Gaucher Disease using spectral domain optical coherent tomography. Sheck LH; Wilson CJ; Vincent AL Ophthalmic Genet; 2012 Dec; 33(4):253-6. PubMed ID: 22950450 [TBL] [Abstract][Full Text] [Related]
9. Enzyme replacement therapy in a child with Gaucher disease. Masood Y; Ali AS J Coll Physicians Surg Pak; 2006 Dec; 16(12):786-8. PubMed ID: 17125641 [TBL] [Abstract][Full Text] [Related]
10. Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: consensus recommendations. Charrow J; Andersson HC; Kaplan P; Kolodny EH; Mistry P; Pastores G; Prakash-Cheng A; Rosenbloom BE; Scott CR; Wappner RS; Weinreb NJ J Pediatr; 2004 Jan; 144(1):112-20. PubMed ID: 14722528 [No Abstract] [Full Text] [Related]
11. Patients with Gaucher type 1: Switching from imiglucerase to miglustat therapy. Canda E; Kose M; Kagnici M; Ucar SK; Sozmen EY; Coker M Blood Cells Mol Dis; 2018 Feb; 68():180-184. PubMed ID: 28111116 [No Abstract] [Full Text] [Related]